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Abstract
Background:  Published articles have described a lack of willingness to allow preventative
measures, as well as other types of modern therapies, as an obstacle to providing medical care for
Amish and Mennonite populations.
Methods: We present data regarding the 12 Amish and Mennonite patients at the SUNY Upstate
Medical University Pediatric Cystic Fibrosis Center and three representative case reports.
Results: Families of patients from these communities receiving care at our Center have accepted
preventive therapy, acute medical interventions including home intravenous antibiotic
administration, and some immunizations for their children with cystic fibrosis, which have improved
the health of our patients. Some have even participated in clinical research trials. Health care
education for both the child and family is warranted and extensive. Significant Cystic Fibrosis
Center personnel time and fundraising are needed in order to address medical bills incurred by
uninsured Amish and Mennonite patients.
Conclusion: Amish and Mennonite families seeking care for cystic fibrosis may choose to utilize
modern medical therapies for their children, with resultant significant improvement in outcome.
Background
While the Amish and Mennonite communities offer the
opportunity for study of closed populations with an
increased incidence of certain genetic disease and defects,
including cystic fibrosis (CF) [1-4], no published data
have dealt with treatment and socioeconomic impact of
CF on Amish and Mennonite families.
In the United States, the population of the Amish in 2001
was reported as approximately 200,000 while the Men-
nonite population was approximately 250,000 [5]. The
incidence of CF among these populations has been diffi-
cult to estimate because of the closed nature of their com-
munities. For example, in one Ohio Amish isolate the
incidence of CF was 1/569 live births, while in another
isolate there was no occurrence of CF among 4448 live
births [6]. The incidence of CF in the general United States
population has been approximately 1/3500 live births,
however this incidence is falling, perhaps as a result of
preconception and prenatal screening offered to the gen-
eral population in order to identify carriers of cystic fibro-
sis [7]. As a majority of Amish and Mennonites may
approve of CF carrier testing that can impact whether CF
carriers marry each other [1], it is possible that these pop-
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ulations also are experiencing a decline in the incidence of
CF. However, the extent of genetic testing and counseling
services available to these communities is unclear [8].
The Mennonites separated from the "Old Order" Amish in
1850 as a result of adoption of new practices by the Men-
nonites, however, many of the central tenants of each
group remain similar [9]. Both the Amish and Mennon-
ites believe that good health is a gift from God, resulting
from hard work and strict obedience to the teachings of
the Bible. The ability to work defines a "healthy" individ-
ual [9-12]. Conversely, illness is generally believed to be
"God's will," while death is considered a natural part of
life and a new beginning, rather than an end or punish-
ment [12]. The Amish and Mennonites believe in the strict
separation of church and state, which historically has
extended to refraining from use of government funds,
including Medicaid and social security [11,12]. Further,
typically they do not purchase commercial insurance [12].
Thus, barriers to provision of modern medical care
include reimbursement issues, as well as the Amish repu-
diation of worldly conveniences such as telephones, elec-
tricity, and automobiles [12].
In most instances of illness, the Amish rely on folk reme-
dies and herbal medications, among other types of "alter-
native" care [12]. Patients coming to modern medical
facilities typically do so with chronic illness of many
years, only after symptoms have become severe and
herbal remedies have not proven beneficial [9]. Such will-
ingness has been attributed to a lack of trained profession-
als within their own communities to deal with severe
illness [11,12].
Contrary to the implications of the literature, we present
data regarding the 12 Amish and Mennonite patients at
the SUNY Upstate Medical University Pediatric CF Center
(8% of our CF patients) along with three representative
case reports in order to alert physicians that families of
these patients can be receptive to modern medical ther-
apy, including preventive measures, which can greatly
benefit the patients. Table 1 shows the proportion of our
Amish and Mennonite patients who have accepted the
recommended standard therapies for CF at our Center.
Nine of the patients have undergone genotype testing and
found to be homozygous for the ΔF508 CF mutation. Five
of the patients have participated in clinical research trials
through our Center.
Due to the small nature of the Amish and Mennonite
communities, we were concerned that members of their
communities could identify the patients in the case
reports. Further, we were concerned by the potential
impact of the current article on such communities [13].
Therefore, following consultation with the SUNY Upstate
Institutional Review Board (IRB), the families of the
patients described in the case reports and their commu-
nity elders reviewed and approved this manuscript prior
to its submission for publication, in order to minimize
risk of group harm, and harm to the families involved in
each of the three presented cases. Approval of the manu-
script also was obtained from the SUNY Upstate IRB.
Case Reports
Patient A – Amish
Patient A was four-years-old when he began receiving care
at our Center. He had multiple siblings, including an
older, much healthier sister who had CF. At the start of
therapy, the patient's parents considered the long-term
prognosis of their son when deliberating what treatments
should be used. Would the disease be painful? What help,
if any, would medications and other medical technology
provide that herbal therapies had not? Is treatment futile
in children with CF?
Following lengthy conversations involving not only the
patient's parents, but also the bishop and elders in his
community, it was felt to be in Patient A's best interest to
begin care with standard therapy for CF at our Center
(Table 1). A gas-powered generator was used to power the
vest. Patient A, as well as all of our Amish and Mennonite
patients, qualified for pharmaceutical companies' patient
assistance programs for many of his medications. Those
medications not covered under individual patient assist-
ance programs were secured from pharmaceutical com-
pany representatives in the form of samples. Our hospital
established a fee reduction program to help offset the cost
of outpatient visits and inpatient hospital admissions for
these families, all of whom qualified based on their
income level. Notably, all of the aforementioned assist-
ance was secured by our CF Center social worker, who was
Table 1: Rate of standard CF therapy use by 12 Amish and 
Mennonite patients at our Center
Chest physiotherapy
Manual percussion 8%
High frequency chest wall oscillator (vest) 86%
Nebulized mucolytic therapy with rhDNase 86%
Multivitamins fortified with vitamins A, D, E, and K 86%
Pancreatic enzymes 100%
Nutritional supplementation 64%
Antibiotic therapy 100%BMC Pediatrics 2009, 9:4 http://www.biomedcentral.com/1471-2431/9/4
Page 3 of 5
(page number not for citation purposes)
vital in communicating with the parents and helping
them complete required paperwork.
While standard therapies appeared to slow progression of
the patient's lung disease, when his status worsened it was
recommended by our Center physician that intravenous
antibiotic therapy be instituted. The family consulted with
their elders who recommended that such therapy be with-
held because of its cost, and as use of such therapy would
only prolong the dying process in a patient with a termi-
nal disease. During discussions with the family, our
Center physician stated that he believed the patient still
would have a reasonable quality of life for several months
or even a few years with use of intravenous antibiotics.
Further, withholding of antibiotic therapy at the time of
the discussions would result in a much longer dying proc-
ess than if the patient lived a longer life with concomitant
lung disease progression prior to withholding of aggres-
sive therapy. After a number of discussions at our Center,
the patient's parents allowed the introduction of intrave-
nous therapy. They stated that if the medications did not
seem to help their son's symptoms, it would be "God's
will." At such a point they would not want to give him fur-
ther intravenous therapy. Home intravenous therapy was
instituted because the family could not afford to pay in-
patient hospital charges.
Several courses of intravenous antibiotic therapy were
associated with a significant improvement of the patient's
respiratory condition. However, after two years, he failed
to respond to two intravenous antibiotic courses. At that
time, the decision was made to withhold further intrave-
nous therapy. The patient was provided supplemental
oxygen at home that was generated by a concentrator, as
well as on-going vest therapy. At the invitation of the
patient and his family, a physician, respiratory therapist,
and social worker from our Center made home visits to
check on the patient as he deteriorated.
As he grew sicker, the patient was prescribed oral narcotics
to be used as necessary for discomfort. Four months after
withholding intravenous therapy, following eight years of
treatment at our Center, Patient A died. According to his
family, as has become custom within this community, all
of his supplies, including the vest and medicines, were
given to another child in the community with CF; in this
case, his sister. The strong bond between the family and
providers at our Center has led to Amish from other com-
munities in New York to seek care at our Center at this
family's advice.
Patient B – Mennonite
At the age of two months, Patient B was seen at another
Center for failure to thrive, emesis, bloody stools, rash
and bruising as a result of a vitamin K deficiency. Follow-
ing an episode of significant cough and wheezing, he was
diagnosed with CF. Later, it was found that Patient B also
had biliary cirrhosis.
After receiving care elsewhere for four years, the patient
came to our Center because his family became discon-
tented with the medical care they had been receiving. The
parents stated they were unhappy because they were not
provided with accurate information regarding the
patient's health condition, need for testing, and treatment
options. Reportedly, the family was told that the patient
would require hospitalization every few months for his
entire life, as well as a liver transplant. The parents report-
edly felt much pressure from staff members of the other
institution to obtain State Aid because of the high on-
going and projected costs of his medical care. Moreover,
herbal remedies that patient B had used since he first
became ill were discouraged by his physician, even
though the family felt his caregivers did little to under-
stand the need for these remedies.
After transferring to our Center, the parents of patient B
were willing to try therapies they had heard worked well
in others with CF in their community, including standard
therapies offered at our Center (Table 1). According to
these parents, their readiness to try such therapies, includ-
ing those that they may have previously rejected, was the
result of the willingness of our Center staff to discuss the
potential benefit and harm of standard as well as alterna-
tive therapies. For example, our CF Center physician was
open to use of herbal therapies for patient B, although he
informed the family that no studies have demonstrated
the effectiveness of treatment of CF. Notably, the deacon
and some of the bishops of patient B's Mennonite com-
munity actively discouraged use of the herbs because their
use was thought to represent witchcraft. This created sig-
nificant discomfort between the family and their bishop.
The parents felt that while some of their community were
supportive of herbs and would be willing to help fund this
therapy, they felt uncomfortable asking for financial
resources from other community members. Ultimately,
without pressure from our Center, the family decided to
obtain insurance coverage through Medicaid.
Four months after institution of our standard CF therapies
and nebulized tobramycin (TOBI®) in treatment of the
patient's airway colonization with Pseudomonas aerugi-
nosa, the patient's pulmonary crackles cleared, and his
hemoglobin saturation in room air rose from 93% to
96%. His body mass index over the same time interval
increased from15.1 kg/m2 (25th percentile for age) to 16.2
kg/m2 (75th percentile for age).
Helping others within their community with CF was an
important aspect of Patient B's overall care, according toBMC Pediatrics 2009, 9:4 http://www.biomedcentral.com/1471-2431/9/4
Page 4 of 5
(page number not for citation purposes)
his parents. Therefore, they consented to his inclusion in
the CF Foundation national patient registry, which tracks
demographics of CF patients throughout the United
States. Moreover, because of the significant history of bil-
iary disease in their child, the parents also consented to
his enrollment in a gene modifier study of patients with
CF liver disease, for which participation consisted of pro-
vision of a single blood specimen.
Patient C – Amish
Patient C was diagnosed with CF following postnatal test-
ing done as a result of a sibling with the disease. She
showed few symptoms of CF until she was two-years-old,
at which time she was brought by her parents to a hospital
in Michigan because she was "pale". While she did not
have any significant respiratory disease prior to this
admission, her condition warranted the start of treatment
for CF including rhDNase, and a bronchodilator, which
largely was covered under Michigan's Trust Fund for Chil-
dren with Special Needs (formerly the Crippled Chil-
dren's fund).
Shortly thereafter, the patient and her family relocated to
another state, where coverage for her expensive therapies
was less available. More importantly to the family, they
"didn't like the doctor" taking care of their children in the
new CF Center because they felt he did little to understand
the beliefs of their culture, and why certain therapies are
accepted while others are not. After talking to others in
their community, the parents of Patient C were told to
come to our Center because of the work we have done
with the Amish. A generator was installed by the family
for the use of a nebulizer and vest. Medications needing
refrigeration have been kept on ice.
Three years ago, the family was contacted by an individual
who sought to, "help Amish children with CF." The family
was presented with a plan to help cover the costs of treat-
ment and were told that it "did not involve government
assistance." Ultimately, this plan turned out to be Medic-
aid through the state of New York, which caused distress
for this family, when they learned about this at a subse-
quent visit to our Center. The social worker at our Center
worked to amend this problem with the State, and assured
the elders and others within their community that the
family in fact did not knowingly apply for state or govern-
mental aid. The family of Patient C was advised by the
social worker to refrain from applying for any sort of
"help" from others outside our facility without first con-
tacting our Center.
The parents consented to have Patient C participate in two
studies, including one involving growth hormone. The
latter study provided reimbursement for the family's
transportation costs to our Center and there were no
charges associated with the Center visits for the duration
of the study. The family also agreed to allow immuniza-
tion for influenza virus on a yearly basis. This family
explained that even though Amish patients often have
refused immunizations of any kind, such preventative
care currently is being left to the family's discretion as atti-
tudes towards preventative care among the Amish have
shifted significantly over the past decade.
Discussion
Publications have described a lack of willingness to allow
preventative measures as an obstacle to providing modern
medical care for Amish and Mennonite populations [10-
12]. Based on the experiences reported by our patients,
this information may have led some within the medical
community to assume that Amish and Mennonite fami-
lies are unwilling to allow preventative care, as well as
other types of modern therapies, which has resulted in
provision of suboptimal care for patients with CF.
Nonetheless, it is evident that Amish and Mennonite fam-
ilies can be open to effective, modern therapy for this dis-
ease. After extensive exploration of the beliefs and
expectations of families from these communities, they
have accepted preventive therapy, acute medical interven-
tions including home intravenous antibiotic administra-
tion, and some immunizations for their children with CF.
Some even have participated in clinical research trials.
Significant CF Center personnel time and fundraising are
needed in order to address medical bills incurred by unin-
sured Amish and Mennonite patients with chronic disease
such as CF. Several options are available. Churches within
the community often have fundraisers, through selling
Amish and Mennonite foods, quilts and furniture. "Amish
Aid" is a type of medical insurance governed by business-
men within the Amish church to help pay for hospital
bills [3]. Such funds are used by members of the church
community, but often fall short of covering costs. With
the availability of programs such as our institution's fee
reduction program to offset costs, caring for Amish
patients becomes more manageable, and helps these fam-
ilies to seek care.
Health care education for both the child and family is war-
ranted and extensive. By openly discussing the rationale
for state-of-the-art and alternative treatments, side effects
and outcomes, Amish and Mennonite families can
embrace state-of-the-art medical therapies, with signifi-
cant positive results. Participation of Amish and Mennon-
ite patients in some of our clinical research trials also has
been very helpful in that participating patients are reim-
bursed for their transportation costs, and clinic charges
are minimized for the duration of studies sponsored by
pharmaceutical companies. Further, participation in suchBMC Pediatrics 2009, 9:4 http://www.biomedcentral.com/1471-2431/9/4
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trials allows for more frequent visits at the CF Center for
the enrolled patients as well as siblings with CF, which
leads to provision of more timely and thus improved
health care.
As presented in this report, some members of each group
also are willing to allow certain preventative measures. A
recent study by Yoder and Dworkin [14], in which ques-
tionnaires were mailed to all households in an Illinois
Amish community, showed that the majority of the com-
munity vaccinates all (84%) or some (12%) of their chil-
dren, with only a small minority objecting due to
concerns about vaccine safety, and an even smaller cohort
objecting due to religious reasons. Thus, Amish families
often are willing to utilize vaccination as a form of pre-
ventative care.
This report illustrates that health care geared to the cul-
tural needs of patients and their families can lead to an
improved outcome. It has been proposed that cultural
sensitivity improves establishment of rapport and thus
promotes cooperation and adherence to therapy [15].
Such sensitivity should include assessment of the patients'
preferences and beliefs, and adjustment of health care
delivery accordingly [16]. For example, in some cultures
more emphasis is placed on collective rather than individ-
ual decision making, communication patterns may differ
(e.g., there may be a relative emphasis on non-verbal com-
munication), and views may differ regarding physicians,
suffering, and the afterlife [16].
Conclusion
It appears essential for the health care team to understand,
consider, and incorporate current beliefs of Amish and
Mennonite communities into the development of effec-
tive programs for treatment of their members with CF.
Similar efforts should be undertaken whenever health
care providers encounter patients from different cultures
or religions.
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